ACYCLOVIR SODIUM FOR INJECTION 1 G
ACYCLOVIR (ACYCLOVIR SODIUM) : 1 G · DIN 02231357 · ABBOTT LABORATORIES, LIMITED
Health Canada status: CANCELLED POST MARKET
What is ACYCLOVIR SODIUM FOR INJECTION?
ACYCLOVIR SODIUM FOR INJECTION 1 G contains ACYCLOVIR (ACYCLOVIR SODIUM) : 1 G. It is listed in the Health Canada Drug Product Database under DIN 02231357, held by ABBOTT LABORATORIES, LIMITED, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 31-Jul-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is ACYCLOVIR SODIUM FOR INJECTION called?
The same molecule, ACYCLOVIR, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| ZOVIRAX | Latin | Bahrain, Saudi Arabia |
| LOVRAK | Latin | Bahrain |
| NOVIRAL | Latin | Bahrain |
| Aciclovir Dawaa Health | Latin | Saudi Arabia |
| Adco Acyclovir Topical Cream | Latin | South Africa |
| DEFORAX | Latin | Bahrain |
| VIRODERM | Latin | Bahrain |
| VIROL | Latin | Bahrain, Saudi Arabia |
| Acyclovir - Vaxcel | Latin | Saudi Arabia |
| Beta-Vira Topical Cream | Latin | South Africa |
| Cyclivex | Latin | South Africa |
| IMAVIR | Latin | Bahrain |
| MEDVIROX | Latin | Bahrain |
| NOVIRAX | Latin | Bahrain |
| VIRPES | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02231357 |
|---|---|
| Brand name | ACYCLOVIR SODIUM FOR INJECTION |
| Generic / active ingredient | ACYCLOVIR (ACYCLOVIR SODIUM) : 1 G |
| Manufacturer | ABBOTT LABORATORIES, LIMITED |
| Strength | 1 G |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | J05AB01 ACYCLOVIR |
| AHFS class | 08:18.32 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-Jul-2007 |
| Original market date | 1998-02-11 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02231357 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2231357 |
| Brand name | ACYCLOVIR SODIUM FOR INJECTION |
| Active ingredient / INN | ACYCLOVIR (ACYCLOVIR SODIUM) : 1 G |
| ATC code | J05AB01 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J05 |
| AHFS class | 08:18.32 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | ABBOTT LABORATORIES, LIMITED |
Which pack is which?
| Strength on the label | 1 G |
|---|---|
| Dosage form | POWDER FOR SOLUTION |
| Route | INTRAVENOUS |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is ACYCLOVIR in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by AURO PHARMA INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code J05AB01 ACYCLOVIR. 15 of 48 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACYCLOVIR SODIUM INJECTION | 50 MG | SOLUTION | EUGIA PHARMA INC. | MARKETED | DIN 02531224 |
| ACYCLOVIR SODIUM INJECTION | 50 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02236926 |
| ACYCLOVIR SODIUM INJECTION | 50 MG | SOLUTION | AURO PHARMA INC | MARKETED | DIN 02494558 |
| APO-ACYCLOVIR | 200 MG | TABLET | APOTEX INC | MARKETED | DIN 02207621 |
| APO-ACYCLOVIR | 400 MG | TABLET | APOTEX INC | MARKETED | DIN 02207648 |
| APO-ACYCLOVIR | 800 MG | TABLET | APOTEX INC | MARKETED | DIN 02207656 |
| MINT-ACYCLOVIR | 200 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02524708 |
| MINT-ACYCLOVIR | 400 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02524716 |
| MINT-ACYCLOVIR | 800 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02524724 |
| MYLAN-ACYCLOVIR | 200 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED | DIN 02242784 |
Who else supplies ACYCLOVIR worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ACYCLOVIR appears in 314 registered pack listings across 12 markets, published on 12 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does ACYCLOVIR cost around the world?
ACYCLOVIR is listed on 6 national price registers Nexara tracks, across 153 pack listings published on 5 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 6 | 78 | 03 Sep 2026 |
| Saudi Arabia | public | 34 | 42 | 01 Sep 2026 |
| Bahrain | retail (max) | 11 | 20 | 01 Sep 2026 |
| South Africa | single exit price | 9 | 11 | 01 Sep 2026 |
| United Arab Emirates | public | 1 | 1 | 31 Aug 2026 |
| Austria | KVP (Kassenverkaufspreis) | 1 | 1 | 03 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.